A new nonprofit organization called 7-HOPE Alliance has launched to defend consumer access to 7-hydroxymitragynine (7-OHM), a kratom-based alkaloid that proponents claim offers a natural alternative to traditional pain management strategies. The organization seeks to combat misinformation and legislative efforts that could restrict access to the compound.
The alliance will focus on three key initiatives: scientific research, public education, and policy advocacy. By commissioning comprehensive studies on 7-OHM's pharmacology and therapeutic potential, 7-HOPE aims to establish an evidence-based understanding of the compound's safety and efficacy.
Jackie Subeck, a board member, emphasized the organization's commitment to supporting individuals who have found limited relief through conventional medical treatments. The alliance will collect and share user testimonials demonstrating how 7-OHM has helped manage complex pain conditions and assisted individuals in transitioning away from potentially harmful synthetic medications.
With mounting pressure from legislative bodies seeking to restrict 7-OHM, the alliance will coordinate efforts to protect legal access and challenge potential bans. By integrating scientific research with personal narratives, 7-HOPE intends to shift public perception and provide a comprehensive, nuanced perspective on the compound's potential benefits.
The organization has already initiated public dialogue, hosting panel discussions at the CHAMPS event in Las Vegas to explore responsible industry practices and consumer education surrounding 7-OHM. As a newly formed nonprofit, 7-HOPE Alliance represents a significant effort to validate and protect access to alternative wellness solutions through rigorous, scientific approaches.
